What does psychosocial functioning mean

A psychosocial disability arises when someone with a mental health condition interacts with a social environment that presents barriers to their equality with others. Someone with a psychosocial disability may require support to overcome the barriers to social inclusion they face. Past experiences of trauma are common for people with psychosocial disability. It is important to be sensitive to the possible impacts of trauma, which may be lifelong, when providing support.

What does psychosocial disability mean to you? Furthermore, data were provided by primary care physicians, psychiatrists and neurologists, representing the full spectrum of HCPs likely to be consulted by patients with MDD in real-world practice.

In terms of this analysis, it should again be noted that comparisons between the two patient cohorts should be interpreted with caution as patient- and HCP-provided responses were unmatched i. In addition, as the survey by definition is cross-sectional, the data presented here cannot be used to draw conclusions about any causal relationship between symptoms of MDD and psychosocial functioning.

In summary, the results suggest that patients and HCPs differ in their perceptions of MDD symptoms and their impact on functioning across all phases of the disease. In particular, patients emphasized cognitive rather than mood and physical symptoms in the acute phase of the disease, while HCPs were more likely than patients to associate more specific physical symptoms with functioning during the remission phase.

The datasets presented in this article are not readily available given the informed consent provided by survey participants.

Requests to access the datasets should be directed to MC. They thus provided consent to receive invitations to participate in market research, and their consent was sought again to participate in this particular study. The market research protocol was not formally approved by a medical ethics committee. MC and BB were both instrumental in the development of the study, study design, analysis plan, and interpretation of data.

CW undertook the statistical analysis and contributed to data interpretation. All authors were involved at all stages of manuscript development and approved the final version. This study was funded by H. MC is an employee of H.

CW is an employee of Lundbeck Singapore Pte. Major depressive disorder: Understanding the significance of residual symptoms and balancing efficacy with tolerability. Am J Med 9 Suppl :S1— Defining and measuring functional recovery from depression. CNS Drugs 24 4 — Neuropsychiatr Dis Treat — Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Google Scholar. The heterogeneity of the depressive syndrome: when numbers get serious. Acta Psychiatr Scand 6 —6. J Affect Disord — American Psychiatry Association. Treating to target in major depressive disorder: response to remission to functional recovery.

CNS Spectr — Disease burden and principles of care. Can J Psychiatry 61 9 — Am J Psychiatry 11 — Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning. Int Clin Psychopharmacol 24 3 —8.

Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25 6 — Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

J Affect Disord 50 2—3 — Psychol Med 40 1 — Am J Psychiatry 11 —6. Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study. Seeing the signs: Using the course of residual depressive symptomatology to predict patterns of relapse and recurrence of major depressive disorder. Depress Anxiety 35 2 — Pharmacological treatments. Treatment goals of depressed outpatients: a qualitative investigation of goals identified by participants in a depression treatment trial.

J Psychiatr Pract 16 6 — Why do some depressed outpatients who are in remission according to the Hamilton Depression Rating Scale not consider themselves to be in remission? J Clin Psychiatry 73 6 —5. What is important in being cured from depression? Discordance between physicians and patients. J Affect Disord —6. Differences in perceptions of major depressive disorder symptoms and treatment priorities between patients and health care providers across the acute, post-acute, and remission phases of depression.

Front Psychiatry Clin Pract Epidemiol Ment Health Baune BT, Air T. Clinical, functional, and biological correlates of cognitive dimensions in major depressive disorder — Rationale, design, and characteristics of the Cognitive Function and Mood Study CoFaM-Study. The role of cognitive impairment in psychosocial functioning in remitted depression. R Core Team. R: A language and environment for statistical computing.

How should remission from depression be defined? Psychol Med 37 09 — Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.

Ro E, Clark LA. Psychosocial functioning in the context of diagnosis: assessment and theoretical issues. Psychol Assess 21 3 Value Health 12 4 —7. Clin Pract Epidemiol Mental Health 3 1 Changes in depression and quality of life during inpatient treatment of depression.

Medicina Kaunas 42 6 —7. Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry 26 1 —7. Baune BT, Air T. Clinical, functional, and biological correlates of cognitive dimensions in major depressive disorder — rationale, design, and characteristics of the cognitive function and Mood Study CoFaM-Study.

Front Psychiatry 7 Neurocognitive deficits and disability in major depressive disorder. Reducing cognitive vulnerability to depression: a preliminary investigation of MEmory Specificity Training MEST in inpatients with depressive symptomatology. J Behav Ther Exp Psychiatry 40 1 — The role of cognitive impairment in general functioning in major depression. Psychiatry Res 2 —9. A review of the role of social cognition in major depressive disorder. Front Psychiatry 5 American Psychiatric Association.

Washington: American Psychological Association; Audioverbal cognitive dysfunction in depression. Factors involved. Prog Neuropsychopharmacol Biol Psychiatry 27 1 — Neuro-cognitive functions in patients of major depression. Indian J Physiol Pharmacol 51 1 The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.

Neuropsychopharmacology 36 12 Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 33 3 — Neurobiol Aging 29 6 — Psychoneuroendocrinology 33 1 — Psychosom Med 71 2 — PLoS One 9 2 :e A meta-analysis of cognitive deficits in first-episode major depressive disorder. J Affect Disord 2 — Cognitive adaptation training: establishing environmental supports to bypass cognitive deficits and improve functional outcomes.

Am J Psychiatr Rehabil 11 2 — The integration of negative affect, pain and cognitive control in the cingulate cortex. Nat Rev Neurosci 12 3 — Portraying emotions at their unfolding: a multilayered approach for probing dynamics of neural networks. Neuroimage 60 2 — Cry for her or cry with her: context-dependent dissociation of two modes of cinematic empathy reflected in network cohesion dynamics.

Soc Cogn Affect Neurosci 9 1 —8. Beck AT. The evolution of the cognitive model of depression and its neurobiological correlates. Am J Psychiatry 8 — Joormann J, Vanderlind WM.

Emotion regulation in depression the role of biased cognition and reduced cognitive control. Clin Psychol Sci 2 4 — Functional anatomy of autobiographical memory recall deficits in depression. Psychol Med 42 02 — Developing cognitive-emotional training exercises as interventions for mood and anxiety disorders.

Eur Psychiatry 30 1 — Cognitive-emotional training as an intervention for major depressive disorder. Depress Anxiety 31 8 — Verbal responses, depressive symptoms, reminiscence functions and cognitive emotion regulation in older women receiving individual reminiscence therapy. J Clin Nurs Forthcoming The Wechsler ACS social perception subtest: a preliminary comparison with other measures of social cognition.

J Psychoeduc Assess 30 5 — Assessment 18 2 — Social emotion recognition, social functioning, and attempted suicide in late-life depression. Am J Geriatr Psychiatry 20 3 — J Nerv Ment Dis 5 —7. Mental state decoding abilities in clinical depression. J Affect Disord 86 2 — Impaired attribution of emotion to facial expressions in anxiety and major depression.

PLoS One 5 12 :e Processing of facial emotion expression in major depression: a review. Aust N Z J Psychiatry 44 8 — Measuring theory of mind in adults with autism spectrum disorder. J Autism Dev Disord 47 7 — Introducing MASC: a movie for the assessment of social cognition.

J Autism Dev Disord 36 5 — Neuropsychological functioning in adolescents and young adults with major depressive disorder — a review. Psychiatry Res 3 — Computerized cognitive training and functional recovery in major depressive disorder: a meta-analysis.

J Affect Disord — Vieta E, Torrent C. Functional remediation: the pathway from remission to recovery in bipolar disorder. World Psychiatry 15 3 —9. Schizophr Res 91 1 —6. Pharmacogenomics in the treatment of mood disorders: strategies and opportunities for personalized psychiatry. EPMA J 8 3 — Neuroplasticity-based computerized cognitive remediation for geriatric depression.

Int J Geriatr Psychiatry 27 12 — Neuroplasticity-based computerized cognitive remediation for treatment-resistant geriatric depression. Nat Commun 5 J Clin Psychiatry 59 — J Clin Psychiatry 71 3 — Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 4 —9. Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis.

Neuropsychology 24 5 Br J Clin Psychol 43 3 — J Pers Soc Psychol 54 6 Williams JBW. A review of self-report instruments measuring health-related work productivity. Pharmacoeconomics 22 4 — Aliment Pharmacol Ther 20 4 — Wagnild G.

A review of the Resilience Scale. J Nurs Meas 17 2 — Development and psychometric evaluation of the Resilience Scale. J Nurs Meas 1 — A review of instruments measuring resilience. Issues Compr Pediatr Nurs 29 2 — Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatr Med 27 2 — Assessing impairment in patients with panic disorder: the Sheehan Disability Scale. Soc Psychiatry Psychiatr Epidemiol 27 2 — Further evidence on dimensionality and correlates of the cognitive failures questionnaire.

Br J Psychol 88 1 — J Neurosci Methods —9. Baddeley AD. Working memory. Working memory control in patients with schizophrenia: a PET study during a random number generation task.

Am J Psychiatry 9 —9. Knight MJ, Tlauka M. Interactivity in map learning: the effect of cognitive load. Spat Cogn Comput 17 3 — Map learning and working memory: multimodal learning strategies.

Q J Exp Psychol :1— Working memory components of the Corsi blocks task. Br J Psychol 95 1 — Examining the role of working memory resources in following spoken instructions.

J Cogn Psychol 28 2 — Clinical usefulness of the screen for cognitive impairment in psychiatry SCIP-S scale in patients with type I bipolar disorder. Health Qual Life Outcomes 7 1 Mood congruence and depressive deficits in memory: a forced-recall analysis. Memory 7 2 —